Holen Sie sich die Stockscreener-App
31.86
0.17%
0.0975
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Axogen Inc Aktie (AXGN) Neueste Nachrichten
A Look At Axogen (AXGN) Valuation After AVANCE BLA Approval And Updated Growth Outlook - simplywall.st
AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum - Yahoo Finance
Axogen at Citizens Life Sciences Conference: Strategic Growth Insights - Investing.com
AxoGen Conference: AVANCE BLA Approval, Debt Paydown Fuel 2026 Growth Target of 18%+ - MarketBeat
Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st
AxoGen at Leerink Conference: Strategic Growth and Market Expansion - Investing.com India
Chipmakers Recap: Is Axogen Inc in a bullish channel2026 Analyst Calls & Accurate Entry/Exit Alerts - baoquankhu1.vn
Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN - MarketBeat
(AXGN) Risk Channels and Responsive Allocation - Stock Traders Daily
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption - National Today
AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference - MarketBeat
AxoGen, Inc. $AXGN Shares Acquired by First Eagle Investment Management LLC - MarketBeat
AXGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Roubaix Capital LLC Purchases New Position in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings - Stock Titan
Axogen (AXGN) innovation chief reports stock awards and tax-share withholding - Stock Titan
Axogen (NASDAQ: AXGN) EVP reports RSU vesting and tax share withholding - Stock Titan
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Axogen, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Axogen, Inc. Rings the Opening Bell - Nasdaq
Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift - simplywall.st
AxoGen Set to Announce Q4 Earnings on February 24 - Intellectia AI
AXGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Wall Street Zen Downgrades AxoGen (NASDAQ:AXGN) to Buy - MarketBeat
AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings Signal A 22.88% Upside Potential - DirectorsTalk Interviews
Equity awards and tax share withholding for Axogen (NASDAQ: AXGN) CFO - Stock Titan
Axogen (NASDAQ: AXGN) CEO granted 98,000 RSUs vesting through 2030 - Stock Titan
Axogen (AXGN) Valuation Check After FDA Avance Approval And New 2026 Growth Targets - Sahm
A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations - Yahoo Finance
AxoGen Posts Strong Growth and Raises Capital With Offering - The Globe and Mail
Citizens reiterates AxoGen stock rating on strong quarterly revenue By Investing.com - Investing.com Nigeria
AxoGen, Inc. (NASDAQ:AXGN) Q4 2025 Earnings Call Transcript - Insider Monkey
axogen Q4 2025 slides: 21% revenue surge, stock tumbles on costs - Investing.com India
Citizens reiterates AxoGen stock rating on strong quarterly revenue - Investing.com
Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc earnings beat by $0.01, revenue topped estimates - Investing.com Australia
Decoding Axogen Inc (AXGN): A Strategic SWOT Insight - GuruFocus
AxoGen, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
axogen Q4 2025 slides: 21% revenue surge, stock tumbles on costs By Investing.com - Investing.com South Africa
Axogen (AXGN) CFO receives 17,500 RSUs and 17,500 shares, 6,704 withheld for taxes - Stock Titan
Axogen (AXGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Axogen Inc (AXGN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
HighMark Wealth Management Buys 158,855 Shares of Axogen Stock - The Globe and Mail
Axogen Inc (AXGN) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Axogen Inc (AXGN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CEO Moves: Is Axogen Inc a play on infrastructure spendingMarket Trend Review & High Return Stock Watch Alerts - baoquankhu1.vn
AxoGen Q4 2025 Earnings Call Transcript - MarketBeat
Axogen, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:AXGN) 2026-02-24 - Seeking Alpha
AxoGen Q4 Earnings Call Highlights - MarketBeat
AXGN Stock: Citizens Maintains Rating, Raises Price Target to $4 - GuruFocus
AxoGen (NASDAQ:AXGN) Shares Gap Down on Disappointing Earnings - MarketBeat
AXGN: 2025 saw 20% revenue growth, FDA BLA approval, and strong outlook for 2026 with 18%+ growth - TradingView
Earnings call transcript: AxoGen Q4 2025 beats forecasts, stock dips By Investing.com - Investing.com India
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Citizens Jmp Boosts AxoGen (NASDAQ:AXGN) Price Target to $42.00 - MarketBeat
AxoGen (AXGN) Q4 Earnings Miss Estimates - Yahoo Finance
AxoGen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Axogen Inc earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com Canada
Earnings call transcript: AxoGen Q4 2025 beats forecasts, stock dips - Investing.com
0.42%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):